Simultaneous treatment of symptomatic cervical and tandem intracranial carotid lesions using transcarotid artery revascularization Authors: Crista E Horton, Julieth D Barbosa, Daniel Shlyak, Alireza Daneshpajouh, Rana El-Tawil, Ahmed K Ghamraoui, John J Ricotta, Joseph J Ricotta Published: 2026 ABSTRACT AbstractA 75-year-old man with recurrent hemispheric stroke was found to have severe tandem cervical and intracranial internal carotid artery (ICA) stenoses and a hostile aortic arch. Transcarotid artery revascularization with flow reversal enabled safe carotid access for angioplasty and stenting of the cervical and intracranial ICA through the same access. Imaging confirmed excellent luminal restoration without complications, and follow-up ultrasound study showed <50% residual stenosis of the cervical ICA along with no new neurologic symptoms. This case demonstrates that transcarotid artery revascularization can facilitate single-session multilevel carotid revascularization in high-risk patients, offering a safe strategy when transfemoral access is unfavorable.Keywords: Transcarotid artery revascularization, Tandem carotid lesions, Carotid stenosis, Endovascular therapy, Hostile aortic arch Tandem cervical and intracranial carotid artery lesions are defined as high-grade stenosis of the cervical internal carotid artery (ICA) with simultaneous high-grade stenosis or thromboembolic occlusion of the intracranial ICA or its terminal branches.1 These lesions are rare, with an incidence of 2% to 4%.2, 3, 4 They account for 15% to 25% of large-vessel acute ischemic strokes and carry higher risk of recurrent cerebrovascular events despite medical management.1,5,6 Patients have worse neurological outcomes than those with isolated intracranial occlusions, with morbidity up to 70% and mortality to 50%.1,7 Management of tandem lesions is technically challenging, particularly when disease involves both carotid bifurcation and intracranial ICA. Traditional approaches include staged or simultaneous transfemoral carotid artery stenting of extracranial and intracranial disease, hybrid strategies combining intracranial stenting followed by carotid endarterectomy, or carotid endarterectomy with retrograde treatment of proximal disease.3,8, 9, 10 Transcarotid artery revascularization (TCAR) has emerged as an alternative to transfemoral carotid artery stenting, offering direct carotid access with flow-reversal cerebral protection while avoiding aortic arch manipulation and reducing embolic risk.11,12 Although staged strategies have been described, guidelines for simultaneous treatment are lacking.9,10 This case highlights the use of TCAR to treat symptomatic cervical ICA stenosis with simultaneous intracranial ICA angioplasty and stenting under flow reversal in a high-risk patient with recurrent ischemic events and hostile aortic arch anatomy. All images and information were obtained with informed consent for publication received from the patient. Case presentation A 75-year-old man recovering from a stroke presented from an inpatient rehabilitation facility with acute right-sided weakness and facial droop. Brain magnetic resonance imaging showed multiple acute left-sided nonhemorrhagic infarcts along with bilateral old infarcts consistent with recurrent left hemispheric stroke. His history included peripheral artery disease, hypertension on three medications, hyperlipidemia on high-intensity statin therapy, type 2 diabetes mellitus with normalized hemoglobin A1c off therapy, chronic kidney disease, and atrial fibrillation managed with apixaban. Three months earlier, he had undergone balloon angioplasty of the left intracranial ICA via a transfemoral approach for acute stroke, complicated by a femoral artery pseudoaneurysm requiring open repair. He was placed on triple antithrombotic therapy for maximum stroke prevention. Both procedures occurred at an outside institution. Current computed tomography angiography (CTA) and magnetic resonance imaging revealed significant left cervical ICA stenosis and significant stenosis of the left petrous and cavernous intracranial ICA (Figs 1 and 2). Mixed atherosclerotic plaque was present at the left carotid bifurcation extending into the ICA. CTA showed extensive diffuse atherosclerotic disease of the aortic arch with calcified plaque involving the origins of the innominate artery, common carotid artery (CCA), and subclavian artery, consistent with a hostile arch anatomy unsuitable for transfemoral access. The right vertebral artery was occluded with distal recanalization. The left vertebral and basilar arteries were patent with antegrade flow. Previous cerebral angiography and current CTA demonstrated adequate cross-filling and preserved cerebral blood volume, suggesting adequate collateralization to tolerate arterial clamping and flow reversal. The patient’s antiplatelet regimen was influenced by a recent gastrointestinal bleed, limiting consistent clopidogrel administration on admission. Platelet function testing demonstrated adequate P2Y12 receptor inhibition; however, repeat testing 3 days before intervention showed reduced antiplatelet responsiveness. The patient was transitioned to ticagrelor, with repeat testing confirming appropriate platelet inhibition before intervention. Thromboelastography demonstrated elevated alpha angle and maximum amplitude, consistent with a hypercoagulable state. A-C, Computed tomography angiography demonstrating tandem left internal carotid artery (ICA) disease. A, Axial view of left common carotid bifurcation showing a complex calcified lesion with soft plaque and stenosis of 50% to 70%. B, Axial view of petrous segment of left ICA showing irregular stenosis of 50% to 70%. C, Reconstruction of cervical carotid artery showing heavily calcified complex plaque at the carotid bifurcation. Lesions are highlighted by yellow ovals. Centerline reconstruction of the left carotid bifurcation showing calcification in the common carotid artery extending into the internal carotid artery with stenosis of 50% to 70%. Given recurrent ischemic events, multiple comorbidities, and hostile aortic arch, a left-sided TCAR was planned to treat both cervical and intracranial carotid lesions while minimizing arch manipulation and embolic risk through flow reversal cerebral protection. Description of procedure The procedure was performed under general anesthesia. The right common femoral vein was accessed under ultrasound guidance and dilated for placement of an 8F sheath. A transverse supraclavicular incision was made between the sternal and clavicular heads of the left sternocleidomastoid muscle. The left CCA was dissected and controlled. After systemic heparinization with activated clotting time >300 seconds, the CCA was accessed antegrade and angiography confirmed significant stenosis of the distal CCA and proximal ICA, as well as stenosis of the petrous and cavernous ICA. An 8F sheath was placed and the ENROUTE flow-reversal system (Silk Road Medical, Inc) was connected to the right femoral vein catheter. After CCA cross-clamping, active flow reversal was initiated. Cerebral oximetry monitoring remained stable during test clamping and was used to monitor toleration of flow reversal. A 0.014-inch wire traversed the cervical lesion, which was treated with balloon angioplasty using a 6 × 30 mm balloon followed by placement of a 9 × 30 mm self-expanding stent. Completion angiography confirmed patency without residual stenosis (Fig 3). Flow reversal during this phase lasted 4 minutes during stent deployment, then was discontinued. This is consistent with our average flow reversal time of 4.6 minutes in over 500 TCAR procedures. Completion angiogram showing patency of the left common carotid artery and internal carotid artery post-transcarotid artery revascularization. There is occlusion of the external carotid artery which was present preoperatively. A neurointerventionalist was involved to address the intracranial lesion. Angiography demonstrated multifocal stenosis of the distal petrous segment and petrouscavernous junction, and focal stenosis of the proximal cavernous ICA. Flow reversal was resumed for an additional 6 minutes, with cumulative duration of 10 minutes. Using a Synchro two microwire (Stryker), and a 3 × 15 mm Gateway balloon (Boston Scientific) for angioplasty, a 4 × 24 mm Neuroform Atlas stent (Stryker) was deployed across both lesions. Postintervention angiography confirmed successful luminal restoration without thrombosis or embolization. The patient tolerated the procedure without complications or intolerance to flow reversal. At 1-month follow-up, carotid ultrasound study demonstrated <50% stenosis of the left CCA and ICA. The patient reported no new neurological symptoms. Planned surveillance included duplex ultrasound guidance at 3 and 6 months, then annually, dual antiplatelet therapy for a year, then single-agent antiplatelet therapy indefinitely. Apixaban was discontinued shortly after due to anemia. Three months later, at a separate encounter, he presented with shortness of breath and urosepsis and died following cardiac arrest, unrelated to the index procedure. Discussion This patient experienced recurrent ischemic symptoms from significant tandem cervical and intracranial ICA stenosis despite previous intracranial angioplasty. TCAR enabled treatment of both lesions while avoiding a hostile aortic arch and providing continuous cerebral protection. Hostile aortic arch and neck anatomy increases embolic risk during transfemoral procedures, particularly in the presence of calcification or “shaggy” plaque.13, 14, 15 TCAR avoids these challenges and facilitates safe multilevel carotid revascularization. Retrograde TCAR approaches to the proximal CCA have been done previously when a CCA access runway was less than the recommended 5 cm.12,16,17 In this case, we did not treat the lesion at the left CCA origin since it was not severe and treatment would have further complicated an already complex procedure. Although concern existed regarding tolerance of flow reversal given extensive great-vessel disease, no preoperative imaging suggested hypoperfusion, and cerebral oximetry remained stable throughout the procedure. Flow reversal intolerance occurs in only 1% to 2% of cases. When cerebral oximetry demonstrates significant desaturation, treatment consists of hemodynamic optimization, transition to low-flow settings, or temporary restoration of antegrade flow, while minimizing clamp time.18,19 Previous treatment of tandem lesions has largely relied on transfemoral access, often in emergent settings requiring cervical carotid stenting before intracranial thrombectomy, an approach associated with both risks and benefits.20, 21, 22 Treating both lesions in a single session under maximal cerebral protection is reasonable in selected high-risk patients, and evidence suggests carotid stenting may improve reperfusion outcomes compared with angioplasty alone in tandem lesions.23,24 Additional approaches – including angioplasty alone or various treatment sequences – have also been proposed.1,25 Novel techniques including the “ReWiSed CARe technique” and “T-Top technique” have been described.26, 27, 28 The T-top technique minimizes procedural time and risk of multistep procedures by using a stent-retriever pusher wire (0.15-0.18 inch), and once released at the intracranial site, a compatible monorail balloon is guided to the level of the extracranial carotid stenosis.26 The ReWiSed CARe technique involves using a stent-retriever as a guidewire, eliminating the need for a long microwire to maintain true lumen position, with antegrade perfusion during tandem lesion treatment.27,28 Although platelet function testing prompted escalation from clopidogrel to ticagrelor before intervention, variability in antiplatelet responsiveness and evidence of a hypercoagulable state may have contributed to the patient’s recurrent ischemic events despite medical therapy. While continued medical management alone could be considered in a frail patient, the presence of ongoing symptomatic tandem lesions and uncertainty regarding therapeutic efficacy supported an interventional approach. In this context, TCAR was pursued following multidisciplinary evaluation and shared decision-making to achieve definitive revascularization and mitigate further stroke risk. Tandem carotid lesions remain complex, with no consensus on treatment sequence, timing, antithrombotic therapy, or follow-up.29 Although long-term outcomes could not be assessed due to the patient’s unrelated death 3 months later, this case highlights that TCAR can provide stable, protected access for simultaneous extracranial and select intracranial carotid intervention. Conclusions Emerging evidence supports TCAR as a versatile tool for extracranial and select intracranial carotid lesions, such as in this patient with symptomatic tandem lesions and high-risk anatomy. Larger studies are needed to define long-term outcomes and optimal patient selection. Funding None. Disclosures None. From the Society for Clinical Vascular Surgery Footnotes The editors and reviewers of this article have no relevant financial relationships to disclose per the Journal policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest. References